Results 31 to 40 of about 20,680 (257)

The clinics of HHV ‐6 infection in COVID ‐19 pandemic: Pityriasis rosea and Kawasaki disease

open access: goldDermatologic Therapy, 2020
A new type of coronavirus family (SARS‐CoV‐2), which can be found in humans and animals, with many varieties and clinical symptoms, was first seen in Wuhan, China in late 2019, under the name novel Coronavirus Disease 2019 (COVID‐19).
Recep Dursun, Selami Aykut Temiz
openalex   +2 more sources

Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines [PDF]

open access: yesJAAD International, 2022
Francesco Drago, MD   +2 more
doaj   +2 more sources

What’s old is new: Valacyclovir for the treatment of pityriasis rosea, a retrospective case series [PDF]

open access: yesJAAD Case Reports, 2023
Gina M. Ashforth, MD   +4 more
doaj   +2 more sources

Clinical and pathological features of 5 cases of children pigmento-genes pityriasis rosea

open access: yesPifu-xingbing zhenliaoxue zazhi, 2022
Objective To analyze clinical manifestations and histopathological features of children patients with pigmento-genes pityriasis rosea. Methods Clinical manifestations, histopathological features and therapeutic responses were retrospectively analyzed for
Ting ZHANG   +5 more
doaj   +1 more source

Pityriasis Rosea Like Drug Rash – A Need to Identify the Disease in Childhood [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Pityriasis rosea is a common dermatosis named by Gibert in 1860. It is an acute self limiting papulosquamous disease, probably infective in origin affecting healthy adolescents and young adults.
Maitreyee Panda   +4 more
doaj   +1 more source

Pityriasis Rosea-like Rash After Messenger Rna Covid-19 Vaccination: a Case Report and Review of the Literature [PDF]

open access: yes, 2022
A spectrum of cutaneous reactions to SARs-CoV-2 (COVID-19) vaccines have been reported in the literature. We present a case of a pityriasis rosea-like rash occurring after Pfizer COVID-19 vaccination and review cases of pityriasis rosea (PR)/PR-like ...
Buckley, Jordan E   +2 more
core   +2 more sources

A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Background: Pityriasis rosea is an acute self-limiting skin disorder of unknown aetiology. Recently human herpes virus 6 and 7 has been hypothesized to be the cause of pityriasis rosea. Objective: To determine the efficacy of acyclovir, an anti-viral
Satyaki Ganguly
doaj   +1 more source

Maculopapular eruptions following COVID‐19 vaccination: Pityriasis rosea or pityriasis rosea‐like eruptions?

open access: yesJournal of Cosmetic Dermatology, 2023
To the Editor, The interesting article by Topal et al.1 about the cutaneous manifestations following COVID19 vaccination, which was recently published in your journal, prompted us to make some observations.
G. Ciccarese   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy